rs187546086

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_025132.4(WDR19):​c.2792A>C​(p.Tyr931Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0056 in 1,613,688 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0059 ( 31 hom. )

Consequence

WDR19
NM_025132.4 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:8

Conservation

PhyloP100: 3.81

Publications

8 publications found
Variant links:
Genes affected
WDR19 (HGNC:18340): (WD repeat domain 19) The protein encoded by this gene is a member of the WD (tryptophan-aspartic acid) repeat family, which is a large family of structurally-related proteins known to participate in a wide range of cellular processes. Each WD repeat typically contains about 40 amino acids that are usually bracketed by glycine-histidine and tryptophan-aspartic acid (WD) dipeptides. This protein contains six WD repeats, three transmembrane domains, and a clathrin heavy-chain repeat. Mutations in this gene have been described in individuals with a wide range of disorders affecting function of the cilium. These disorders are known as ciliopathies, and include Jeune syndrome, Sensenbrenner syndromes, Senior-Loken syndrome, combined or isolated nephronophthisis (NPHP), and retinitis pigmentosa (RP). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
WDR19 Gene-Disease associations (from GenCC):
  • asphyxiating thoracic dystrophy 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cranioectodermal dysplasia 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nephronophthisis 13
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Senior-Loken syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cranioectodermal dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.022140175).
BP6
Variant 4-39253208-A-C is Benign according to our data. Variant chr4-39253208-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167843.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00259 (394/152330) while in subpopulation NFE AF = 0.00492 (335/68036). AF 95% confidence interval is 0.00449. There are 0 homozygotes in GnomAd4. There are 163 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 31 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR19NM_025132.4 linkc.2792A>C p.Tyr931Ser missense_variant Exon 25 of 37 ENST00000399820.8 NP_079408.3 Q8NEZ3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR19ENST00000399820.8 linkc.2792A>C p.Tyr931Ser missense_variant Exon 25 of 37 1 NM_025132.4 ENSP00000382717.3 Q8NEZ3-1
WDR19ENST00000506869.5 linkn.*2373A>C non_coding_transcript_exon_variant Exon 24 of 36 2 ENSP00000424319.1 D6RBA0
WDR19ENST00000512095.5 linkn.1790A>C non_coding_transcript_exon_variant Exon 15 of 23 2
WDR19ENST00000506869.5 linkn.*2373A>C 3_prime_UTR_variant Exon 24 of 36 2 ENSP00000424319.1 D6RBA0

Frequencies

GnomAD3 genomes
AF:
0.00259
AC:
394
AN:
152212
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000892
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00492
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00279
AC:
695
AN:
248780
AF XY:
0.00282
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.000524
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00107
Gnomad NFE exome
AF:
0.00550
Gnomad OTH exome
AF:
0.00265
GnomAD4 exome
AF:
0.00592
AC:
8650
AN:
1461358
Hom.:
31
Cov.:
31
AF XY:
0.00572
AC XY:
4156
AN XY:
726944
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33468
American (AMR)
AF:
0.000627
AC:
28
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86200
European-Finnish (FIN)
AF:
0.000937
AC:
50
AN:
53386
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5764
European-Non Finnish (NFE)
AF:
0.00754
AC:
8382
AN:
1111726
Other (OTH)
AF:
0.00255
AC:
154
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
435
870
1305
1740
2175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00259
AC:
394
AN:
152330
Hom.:
0
Cov.:
31
AF XY:
0.00219
AC XY:
163
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41580
American (AMR)
AF:
0.000850
AC:
13
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00492
AC:
335
AN:
68036
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00442
Hom.:
15
Bravo
AF:
0.00278
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00109
AC:
4
ESP6500EA
AF:
0.00561
AC:
46
ExAC
AF:
0.00265
AC:
320
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00475
EpiControl
AF:
0.00516

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:2
Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The WDR19 c.2792A>C; p.Tyr931Ser variant (rs187546086), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 167843). This variant is found in the general population with an overall allele frequency of 0.27% (768/280184 alleles, including a single homozygote) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.308). While the relatively high population frequency suggests that this is likely a benign variant, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 03, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 15, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Nov 18, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2792A>C (p.Y931S) alteration is located in exon 25 (coding exon 25) of the WDR19 gene. This alteration results from a A to C substitution at nucleotide position 2792, causing the tyrosine (Y) at amino acid position 931 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Connective tissue disorder Uncertain:1
Mar 01, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Asphyxiating thoracic dystrophy 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

WDR19-related disorder Benign:1
May 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Cranioectodermal dysplasia 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Asphyxiating thoracic dystrophy 5;C4225376:Senior-Loken syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
20
DANN
Benign
0.94
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.16
Eigen_PC
Benign
0.052
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.022
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
1.6
L
PhyloP100
3.8
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-2.0
N
REVEL
Uncertain
0.31
Sift
Benign
0.39
T
Sift4G
Benign
0.39
T
Polyphen
0.010
B
Vest4
0.71
MVP
0.76
MPC
0.24
ClinPred
0.027
T
GERP RS
5.5
Varity_R
0.15
gMVP
0.59
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs187546086; hg19: chr4-39254828; COSMIC: COSV56470385; API